264 related articles for article (PubMed ID: 27245865)
41. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
[TBL] [Abstract][Full Text] [Related]
42. Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway.
Ratkaj I; Bujak M; Jurišić D; Baus Lončar M; Bendelja K; Pavelić K; Kraljević Pavelić S
Cell Physiol Biochem; 2012; 30(4):927-42. PubMed ID: 22965824
[TBL] [Abstract][Full Text] [Related]
43. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
Jemec B; Linge C; Grobbelaar AO; Smith PJ; Sanders R; McGrouther DA
Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
[TBL] [Abstract][Full Text] [Related]
44. Down-regulation of collagen synthesis and matrix metalloproteinase expression in myofibroblasts from Dupuytren nodule using adenovirus-mediated relaxin gene therapy.
Kang YM; Choi YR; Yun CO; Park JO; Suk KS; Kim HS; Park MS; Lee BH; Lee HM; Moon SH
J Orthop Res; 2014 Apr; 32(4):515-23. PubMed ID: 24293067
[TBL] [Abstract][Full Text] [Related]
45. Metabolism and proliferation of cultured fibroblasts from specimens of human palmar fascia and Dupuytren's contracture. The pathobiochemistry of connective tissue proliferation, II.
Delbrück A; Schröder H
J Clin Chem Clin Biochem; 1983 Jan; 21(1):11-7. PubMed ID: 6854215
[TBL] [Abstract][Full Text] [Related]
46. Distribution of ED-A and ED-B containing fibronectin isoforms in Dupuytren's disease.
Halliday NL; Rayan GM; Zardi L; Tomasek JJ
J Hand Surg Am; 1994 May; 19(3):428-34. PubMed ID: 8056970
[TBL] [Abstract][Full Text] [Related]
47. Association of advanced glycation end products in Dupuytren disease.
Takase F; Mifune Y; Inui A; Ueda Y; Kataoka T; Kokubu T; Kuroda R
J Orthop Surg Res; 2018 Jun; 13(1):143. PubMed ID: 29880057
[TBL] [Abstract][Full Text] [Related]
48. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
Ulrich D; Ulrich F; Piatkowski A; Pallua N
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
[TBL] [Abstract][Full Text] [Related]
49. Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease.
Bayat A; Watson JS; Stanley JK; Alansari A; Shah M; Ferguson MW; Ollier WE
J Bone Joint Surg Br; 2002 Mar; 84(2):211-5. PubMed ID: 11924651
[TBL] [Abstract][Full Text] [Related]
50. Dupuytren's contracture: morphological and biochemical changes in palmar aponeurosis.
Hamamoto H; Ueba Y; Sudo Y; Sanada H; Yamamuro T; Takeda T
Hand; 1982 Oct; 14(3):237-47. PubMed ID: 6130030
[TBL] [Abstract][Full Text] [Related]
51. Dupuytren's contracture: an update of biomolecular aspects and therapeutic perspectives.
Cordova A; Tripoli M; Corradino B; Napoli P; Moschella F
J Hand Surg Br; 2005 Dec; 30(6):557-62. PubMed ID: 16168532
[TBL] [Abstract][Full Text] [Related]
52. Fibrin/fibrinogen and fibrinolytic activity of the palmar fascia in Dupuytren's contracture.
Merlo G; Ambroggio GP; Castagna B; Mosca A; Oberto E
J Hand Surg Br; 1986 Feb; 11(1):55-7. PubMed ID: 3958550
[TBL] [Abstract][Full Text] [Related]
53. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro.
Rayan GM; Parizi M; Tomasek JJ
J Hand Surg Am; 1996 Nov; 21(6):1065-70. PubMed ID: 8969433
[TBL] [Abstract][Full Text] [Related]
54. [Collagen metabolism in Dupuytren's contracture].
Balaba TIa; Furtseva LN; Shinkarenko IN; Abdurazakov UA
Vopr Med Khim; 1978; 24(6):818-21. PubMed ID: 734986
[TBL] [Abstract][Full Text] [Related]
55. The importance of genetic susceptibility in Dupuytren's disease.
Becker K; Tinschert S; Lienert A; Bleuler PE; Staub F; Meinel A; Rößler J; Wach W; Hoffmann R; Kühnel F; Damert HG; Nick HE; Spicher R; Lenze W; Langer M; Nürnberg P; Hennies HC
Clin Genet; 2015 May; 87(5):483-7. PubMed ID: 24749973
[TBL] [Abstract][Full Text] [Related]
56. SNPs previously associated with Dupuytren's disease replicated in a North American cohort.
Anderson ER; Ye Z; Caldwell MD; Burmester JK
Clin Med Res; 2014 Dec; 12(3-4):133-7. PubMed ID: 24573701
[TBL] [Abstract][Full Text] [Related]
57. Biomimetic analyses of interactions between macrophages and palmar fascia myofibroblasts derived from Dupuytren's disease reveal distinct inflammatory cytokine responses.
Gonga-Cavé BC; Pena Diaz AM; O'Gorman DB
Wound Repair Regen; 2021 Jul; 29(4):627-636. PubMed ID: 34212454
[TBL] [Abstract][Full Text] [Related]
58. Enzymes of glucose metabolism in palmar fascia and Dupuytren's contracture.
Hoopes JE; Jabaley ME; Su CT; Wilgis S; Im MJ
J Hand Surg Am; 1977 Jan; 2(1):62-5. PubMed ID: 190288
[TBL] [Abstract][Full Text] [Related]
59. Evidence for type V and I trimer collagens in Dupuytren's Contracture palmar fascia.
Ehrlich HP; Brown H; White BS
Biochem Med; 1982 Dec; 28(3):273-84. PubMed ID: 6819866
[No Abstract] [Full Text] [Related]
60. IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease.
Raykha C; Crawford J; Gan BS; Fu P; Bach LA; O'Gorman DB
Biochim Biophys Acta; 2013 Oct; 1832(10):1511-9. PubMed ID: 23623986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
